The "ANCA Anti Neutrophil Cytoplasmic Antibodies Positive Reflex to ANCA-MPO and ANCA-PR3 Test" is a sophisticated diagnostic procedure designed to detect the presence of specific antibodies known as ANCA (Anti-Neutrophil Cytoplasmic Antibodies) in the bloodstream. These antibodies are significant markers for certain autoimmune disorders, particularly vasculitis types such as Granulomatosis with Polyangiitis (GPA, formerly known as Wegener's granulomatosis) and Microscopic Polyangiitis (MPA).
Upon identifying a positive ANCA result, this test reflexively differentiates between the two main types of ANCA: MPO-ANCA (Myeloperoxidase-ANCA) and PR3-ANCA (Proteinase 3-ANCA). This differentiation is crucial as it helps in pinpointing the specific type of autoimmune vasculitis, thereby guiding the treatment plan.
The test is conducted at DNA Labs UAE, a state-of-the-art facility known for its accuracy and reliability in diagnostic services. The cost of the test is set at 820 AED. This comprehensive testing approach is essential for the timely and accurate diagnosis of ANCA-associated vasculitides, enabling healthcare providers to initiate the most effective treatment strategies for affected individuals.
The ANCA (Antineutrophil Cytoplasmic Antibodies) IFA (Indirect Fluorescent Antibody) in Dilutions Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to detect the presence of ANCA in the blood. These antibodies are primarily associated with autoimmune vasculitis, a condition characterized by the inflammation of blood vessels, which can lead to significant organ damage. The test plays a crucial role in diagnosing and managing diseases such as Granulomatosis with Polyangiitis (Wegener's Granulomatosis) and Microscopic Polyangiitis, among others.
Performed at a cost of 820 AED, the ANCA IFA in Dilutions Test involves collecting a blood sample from the patient, which is then subjected to a series of dilutions to identify the presence and pattern of ANCA. The IFA technique is employed to visualize the antibodies, offering insights into the specific type of vasculitis, thereby guiding treatment strategies. DNA Labs UAE is equipped with state-of-the-art facilities to ensure accurate and reliable results, making it a preferred choice for patients and healthcare providers seeking comprehensive autoimmune diagnostics.
The Bone and Joint Disease Panel Serum Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to evaluate various markers associated with bone and joint health. Priced at 820 AED, this test aims to detect and monitor conditions such as osteoporosis, arthritis, and other bone-related diseases by analyzing specific biomarkers in the serum component of blood. By providing a detailed insight into the biochemical status of bones and joints, this test helps in the early detection of potential issues, allowing for timely intervention and management. Performed in the state-of-the-art facilities of DNA Labs UAE, this panel is crucial for individuals experiencing symptoms related to bone and joint disorders or those at risk due to genetic predisposition or lifestyle factors.
The C1q Complement Test is a specialized blood test designed to measure the levels of the C1q protein, a crucial component of the complement system in the human immune system. This test is often utilized to help diagnose and monitor various autoimmune and immune complex diseases, such as systemic lupus erythematosus (SLE), where the complement system plays a significant role in the disease's pathology.
At DNA Labs UAE, this test is available for a cost of 820 AED. DNA Labs UAE is known for its state-of-the-art facilities and highly accurate diagnostic procedures, ensuring reliable results for patients. The test involves a simple blood draw, after which the sample is analyzed to determine the concentration of C1q protein. The results can provide valuable insights into the patient's immune system status and help guide treatment decisions for conditions related to the complement system.
The Chlamydia Trachomatis PCR (Polymerase Chain Reaction) test is a highly sensitive and specific diagnostic tool used to detect the presence of Chlamydia trachomatis bacteria, which is a common sexually transmitted infection (STI). This test is crucial for the early detection and treatment of the infection to prevent long-term health issues. By amplifying the DNA of the bacteria, the PCR method can identify an infection even when the bacterial load is low, making it more reliable than traditional culture methods.
At DNA Labs UAE, the test is offered for a cost of 820 AED. The laboratory utilizes state-of-the-art PCR technology to ensure accurate and rapid results, helping individuals receive timely treatment. The process involves collecting a swab or urine sample from the patient, which is then analyzed in the lab for the presence of Chlamydia trachomatis DNA. Given its accuracy and efficiency, the Chlamydia Trachomatis PCR Test is a valuable resource in the management and control of this STI within the community.
Chromosome Analysis for Hematologic Malignancy Test is a critical diagnostic tool used in the medical field to identify and understand various blood cancers, including leukemia, lymphoma, and myeloma. This test examines chromosomes in blood or bone marrow cells to detect abnormalities that may indicate the presence of a hematologic malignancy. Chromosomal abnormalities, such as translocations, deletions, or duplications, play a significant role in the diagnosis, prognosis, and treatment planning of these diseases.
Performed at DNA Labs UAE, a leading laboratory known for its advanced diagnostic techniques and accuracy, the test provides crucial insights into the genetic makeup of the malignancy. This information is vital for determining the most effective treatment strategy for the patient. The cost of the Chromosome Analysis for Hematologic Malignancy Test at DNA Labs UAE is 820 AED. This investment in one's health can lead to a more targeted and successful treatment approach, potentially improving patient outcomes in the fight against blood cancers.
Chronic Fatigue Syndrome (CFS), also known as Myalgic Encephalomyelitis (ME), is a complex and challenging condition characterized by extreme fatigue that doesn't improve with rest and worsens with physical or mental activity. Diagnosing CFS can be difficult as its symptoms overlap with many other conditions.
At DNA Labs UAE, a specialized test is available to assist in the diagnosis of Chronic Fatigue Syndrome. This test aims to identify specific biomarkers and genetic predispositions associated with CFS, offering a more targeted approach to understanding the patient's condition. The test is priced at 820 AED, making it accessible for individuals seeking insights into their unexplained fatigue and related symptoms.
The process at DNA Labs UAE involves a simple and non-invasive procedure, ensuring a comfortable experience for the patient. After the test, comprehensive results are provided, which can be crucial for the healthcare provider in formulating a personalized treatment plan. This test is a valuable tool in the diagnostic process, offering hope and direction for those affected by this debilitating syndrome.
The Chronic Lymphocytic Leukemia (CLL) Mutations Detection Panel 2 Test is a sophisticated diagnostic tool offered by DNA Labs UAE, designed to identify specific genetic mutations associated with CLL. This test plays a crucial role in understanding the genetic landscape of an individual's leukemia, which can significantly influence treatment decisions and prognostic assessments. By analyzing the DNA from a patient's blood or bone marrow sample, the panel screens for a range of mutations known to be involved in CLL pathogenesis.
The cost of the CLL Mutations Detection Panel 2 Test is 820 AED. The price reflects the comprehensive nature of the test, as it encompasses a broad spectrum of genetic markers that are crucial for tailoring patient-specific therapeutic strategies. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test is a pivotal resource for healthcare providers in the management of CLL, offering insights that can lead to more personalized and effective treatment plans.
The "Chronic Lymphocytic Leukemia (CLL) Mutations Detection Panel 1 Test" is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify specific genetic mutations associated with CLL. This test plays a crucial role in the precise diagnosis and management of CLL, a type of cancer characterized by the accumulation of abnormal lymphocytes in the blood and bone marrow. By analyzing the patient's DNA, the test can detect mutations that are known to influence the disease's behavior, prognosis, and response to treatment. The cost of the test is 820 AED, making it a valuable tool for healthcare professionals in tailoring personalized treatment plans for CLL patients, enhancing the effectiveness of therapy, and potentially improving patient outcomes.
The Des-Gamma Carboxy Prothrombin (DCP), also known as Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II), Serum Test is a specialized diagnostic assessment available at DNA Labs UAE. This test is designed to measure the levels of Des-Gamma Carboxy Prothrombin in the blood, which is a non-functional precursor of prothrombin. Elevated levels of DCP/PIVKA-II are often associated with liver dysfunction and can be particularly indicative of hepatocellular carcinoma (HCC), a common type of liver cancer.
The test is crucial for individuals at risk of liver diseases or for those being monitored for the progression or treatment response of liver cancer. By detecting abnormal levels of DCP, healthcare providers can make more informed decisions regarding the diagnosis, prognosis, and treatment strategies for affected patients.
At DNA Labs UAE, the Des-Gamma Carboxy Prothrombin (DCP/PIVKA-II) Serum Test is offered at a cost of 820 AED. The facility ensures accurate and reliable results, utilizing state-of-the-art technology and methodologies to support patient care and disease management.
